Role of Angiotensin II in the Remodeling Induced by a Chronic Increase in Flow in Rat Mesenteric Resistance Arteries

Hypertension - Tập 55 Số 1 - Trang 109-115 - 2010
Maud Cousin1,2, Marc‐Antoine Custaud2, Céline Baron‐Menguy2, Bertrand Toutain3,2, Odile Dumont2, Anne‐Laure Guihot2, Emilie Vessières2, Jean‐François Subra1,3,2, Daniel Henrion1,2, Laurent Loufrani2
1Centre Hospitalier Universitaire d'Angers
2Laboratoire de Biologie Neurovasculaire Intégrée [Angers]
3Centre de Recherche en Cancérologie Nantes-Angers

Tóm tắt

Angiotensin II is a potent growth factor involved in arterial wall homeostasis. In resistance arteries, chronic increases in blood flow induce a rise in diameter associated with arterial wall hypertrophy. Nevertheless, the role of angiotensin II in this remodeling is unknown. We investigated the effect of blocking angiotensin II production or receptor activation on flow-induced remodeling of mesenteric resistance arteries. Arteries were ligated in vivo to generate high-flow arteries compared with normal flow (control) vessels located at a distance. Arteries were isolated after 1 week for in vitro analysis. Arterial diameter, media surface, endothelial NO synthase expression, superoxide production, and extracellular signal–regulated kinase 1/2 phosphorylation were higher in high-flow than in control arteries. Angiotensin-converting enzyme inhibition (perindopril) and angiotensin II type 1 receptor blockade (candesartan) prevented arterial wall hypertrophy without affecting diameter enlargement. The nonselective vasodilator hydralazine had no effect on remodeling. Although perindopril and candesartan increased endothelial NO synthase expression in high-flow arteries, hypertrophy remained in rats treated with N G -nitro- l -arginine methyl ester and mice lacking endothelial NO synthase. Perindopril and candesartan reduced oxidative stress in high-flow arteries, but superoxide scavenging did not prevent hypertrophy. Both Tempol and the absence of endothelial NO synthase prevented the rise in diameter in high-flow vessels. Extracellular signal–regulated kinase 1/2 activation in high-flow arteries was prevented by perindopril and candesartan and not by hydralazine. Extracellular signal–regulated kinase 1/2 inhibition in vivo (U0126) prevented hypertrophy in high-flow arteries. Thus, a chronic rise in blood flow in resistance arteries induces a diameter enlargement involving NO and superoxide, whereas hypertrophy was associated with extracellular signal–regulated kinase 1/2 activation by angiotensin II.

Từ khóa


Tài liệu tham khảo

Mulvany MJ. Small artery remodeling and significance in the development of hypertension. News Physiol Sci. 2002; 17: 105–109.

10.1016/0014-2999(92)94812-A

10.1016/j.ejphar.2007.03.053

10.1152/ajpcell.00287.2006

10.1016/S0026-0495(98)90366-3

10.1007/s11906-003-0073-2

10.1016/j.amjhyper.2005.05.005

10.1152/ajpheart.00800.2004

Lehoux S, Tronc F, Tedgui A. Mechanisms of blood flow-induced vascular enlargement. Biorheology. 2002; 39: 319–324.

10.1152/ajpheart.1997.273.4.H1699

10.1161/01.res.0000047505.11002.81

10.1161/hypertensionaha.107.088716

10.1161/01.atv.0000254684.80662.44

10.1161/hyp.34.4.659

10.1038/sj.bjp.0703371

10.1161/res.80.2.189

10.1161/res.79.5.1015

10.1080/10739680902816301

10.1006/mvre.2002.2417

10.1016/S0014-2999(98)00616-5

10.1097/00004872-199602000-00005

10.1161/01.cir.0000156503.62815.48

10.1159/000065547

10.1161/atvbaha.108.171751

10.1152/ajpheart.00074.2004

10.1093/cvr/cvn334

10.1093/cvr/cvm055

10.1152/ajpheart.1998.274.4.H1301

10.1152/ajpheart.00118.2003

10.1152/ajpheart.00836.2003

10.1038/sj.mn.7800151

10.1007/s00418-004-0696-7

10.1161/01.res.0000181759.63239.21

10.1161/01.hyp.0000182660.74266.6d

10.1161/01.hyp.24.3.317

10.1093/cvr/cvn050

10.1152/ajpheart.91406.2007

10.1152/ajpheart.2001.281.1.H30

10.1161/01.hyp.17.5.626

10.1186/1471-2261-4-6

10.1385/CBB:47:1:1

Thông tin
Thông tin xuất bản

Hypertension

Tập 55 Số 1

109-115

Thông tin tác giả